发明名称 |
ORGANIC ANION TRANSPORT POLYPEPTIDE RELATED PROTEIN-4 (OATPRP4) GENE IN TOURETTE SYNDROME AND RELATED DISORDERS |
摘要 |
The present invention identifies that modification, i.e., disruption, of the OATPRP-4 gene and/or its protein product(s) correlates with the predisposition for Tourette syndrome (TS) and/or related disorders. Provided herein, therefore, is a research model for screening compounds and/or small molecules for the ability to reduce, ameliorate or modulate TS and/or related disorders by administering the compound or small molecule to a transgenic animal having a disrupted OATPRP-4 gene and/or protein product(s) of the gene and then measuring or observing if the compound or small molecule reduces, ameliorates or modulates signs and/or symptoms of TS and/or related disorders. Additionally, a research model is provided using an human or animal cell line having a disrupted OATPRP-4 gene and/or protein product(s) of the gene, as well as methods for diagnosing and treating animals or humans having a predisposition for or manifesting symptoms of TS and/or related disorders. Finally, the present invention provides a transgenic animal model, an animal cell line, an animal primary cell culture line of a transgenic animal, a human cell line, and a human primary cell culture line, all of which have a disruption of a OATPRP-4 gene or a disruption of a homologue of the OATPRP-4 gene therein. |
申请公布号 |
WO2004042035(A2) |
申请公布日期 |
2004.05.21 |
申请号 |
WO2003US35372 |
申请日期 |
2003.11.05 |
申请人 |
UNIVERSITY OF SOUTH FLORIDA;CRAWFORD, FIONA, C.;AIT-GHEZALA, GHANIA;MULLAN, MICHAEL, J. |
发明人 |
CRAWFORD, FIONA, C.;AIT-GHEZALA, GHANIA;MULLAN, MICHAEL, J. |
分类号 |
A01K67/027;C07K14/47;C07K14/705;C12N5/02 |
主分类号 |
A01K67/027 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|